Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies - Concepedia

Concepedia

Publication | Closed Access

Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies

41

Citations

27

References

2003

Year

Hans‐Heinrich Wolf, S.V. Davies, Michael Borte, Mathieu Caulier, P Williams, Horst von Bernuth, William Egner, I. Sklenar, Carolyn E. Adams, Peter Späth,

Abstract

IVIG-N is efficacious, well tolerated and safe in patients with ITP and PID. Its pharmacokinetic properties were comparable to those of Sandoglobulin.

References

	Year	Citations

Page 1